AstraZeneca is a global pharmaceutical company combining Swedish and British innovation.
SwedCham China, together with the Swedish Chambers around the APAC region, are delighted to welcome Mr Leon Wang, Executive Vice President International and CEO China of AstraZeneca, to this APAC webinar for SwedCham members only.
We will get the opportunity to hear about AstraZeneca's efforts to overcome the COVID-19 pandemic, its focus on harnessing the power of science, digital innovation and partnership to build more resilient healthcare systems post-pandemic, and their determination to make health happen for as many people, in as many countries as possible.
AstraZeneca develops, manufactures and sells pharmaceuticals and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.
AstraZeneca has its corporate headquarters in Cambridge, United Kingdom, and its main research and development (R&D) centers are in Cambridge (UK), Gaithersburg (Maryland, US), Gothenburg (Sweden) and Warsaw (Poland).
Moderator for this webinar is Mr. Peter Ling-Vannerus, Chief Representative of SEB Beijing.
The event is free of charge and exclusive to SwedCham Members.
When: March 10 at 4 PM (GMT+8)
Where: Online, using SwedCham China's online platform KUDO
This Webinar will be conducted on the SwedCham China platform KUDO! KUDO makes it possible for our audiences to switch languages between English and Chinese with a simple click in the meeting room. Link to access the meeting will be sent out the same day as the webinar.
Executive Vice President International and CEO China of AstraZeneca China at AstraZeneca Hong Kong Ltd
Chief Representative at SEB (Skandinaviska Enskilda Banken)
KUDO (Online Platform)
For additional event or venue information, please send an email to firstname.lastname@example.org